Illumina Ventures

Venture firm

Illumina Ventures investment thesis

main Illumina Ventures Illumina Ventures is the leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation as we accelerate the impact on human health. About Us Your browser does not support the video element. slider-portfolio Portfolio Spotlight Measuring previously undetectable structural changes in biomolecules. Read More “RedShiftBio’s mission is to deploy the power of novel analytical tools in life science research and biopharmaceutical drug development, tackling previously unsolvable problems in structural biology.” Julien Bradley, CEO Making single cell sequencing more efficient and accessible. Read More “Single-cell RNA sequencing is a critical tool in understanding complex biological processes. Fluent Biosciences is

Illumina Ventures team (8)

Partners and principals at Illumina Ventures:

Illumina Ventures portfolio companies

Companies listed on Illumina Ventures's public materials include: About, Labs, Team, Portfolio, News, Investors Login, Our Portfolio, Actym Therapeutics, View Company, Alamar Biosciences, Arbor Biotechnologies, Arima Genomics, Attovia Therapeutics, Broken String Biosciences, Bullseye Biosciences, Cernostics, CuBaseBio, DeepSeq.AI, Delfi Diagnostics, DNAScript, Encoded Therapeutics, Fluent BioSciences, Fuze Health, Genome Medical, Hepta Bio, Iambic Therapeutics, Infinity Bio, Integrated Biosciences, Kallyope, Kodikaz, Lightcast Bio, NanoCellect Biomedical, NuCicer, Oncko, Pattern, Pluton Biosciences, Precede Biosciences, Predicta Biosciences, Protillion Biosciences, Redshift Bio, Ribometrix, Serinus Biosciences, Sherlock Biosciences, Sonothera, Stilla Technologies, Syntax Bio, Tagomics, Content Type: Page Template, Template: Default, ID: 108, 108.

Is Illumina Ventures a fit for your round?

Upload your pitch deck and see whether anyone at Illumina Ventures appears in your top matches.

Find investors for your deck